H-DL-Leu-OBzl · p-tosylate

H-DL-Leu-OBzl · p-tosylate is a protected leucine derivative in which the amino group is acetylated (N-acetyl, H-DL-Leu-) and the carboxyl functionality is present as a benzyl ester (OBzl), while the overall material is associated with a p-toluenesulfonate counterion. The molecule contains the leucine side chain with an isobutyl group, providing a hydrophobic aliphatic handle that can influence peptide microenvironments and downstream solubility. DL stereochemistry indicates a racemic mixture at the α-carbon, which is relevant for developing racemate-based libraries, method screening, or later stereochemical resolution strategies. Benzyl ester protection and N-acetylation shape its reactivity profile for peptide coupling chemistry and controlled deprotection, and the tosylate association can improve handling and salt-form stability during synthetic operations.

1. Peptide Synthesis

H-DL-Leu-OBzl · p-tosylate serves as an amino acid ester building block for peptide coupling workflows where N-acetyl and benzyl ester protection support stepwise chain assembly. The benzyl ester can participate in controlled C-terminal strategies, enabling conversion to a free acid or activation for further transformations after deprotection, while the N-acetyl group modulates amine reactivity during coupling. The leucine side chain contributes hydrophobic character useful for constructing peptide segments that mimic natural protein core environments. Racemic (DL) stereochemistry can be applied in peptide library synthesis, where mixture-based analogs are screened prior to stereodefined optimization, supporting downstream SAR studies and method development in peptide chemistry.

2. Protected Amino Acid Chemistry

H-DL-Leu-OBzl · p-tosylate functions as a protected amino acid intermediate for derivatization routes that require orthogonal protection and predictable functional group behavior. The N-acetylated amine and benzyl ester provide a protected amino acid framework that can be selectively manipulated through deprotection and reactivation steps, supporting formation of activated derivatives for subsequent coupling or functionalization. The p-tosylate association can be leveraged for improved material handling in synthesis planning, particularly when preparing intermediates for continuous or batch fine chemical production. Downstream utility includes converting the benzyl ester into alternative C-terminal protecting-group patterns and generating additional protected leucine analogs for peptide building block preparation and industrial intermediate supply.

3. Chiral Resolution Screening

H-DL-Leu-OBzl · p-tosylate can be used in chiral synthesis development because it is explicitly provided as a DL leucine derivative, enabling stereochemical separation or stereochemical assignment strategies downstream. The α-stereocenter bearing the leucine side chain allows formation of diastereomeric derivatives when paired with chiral reagents, supporting analytical monitoring and process development for enantiomer-enriched amino acid intermediates. The benzyl ester and N-acetyl protection provide functional-group stability during resolution experiments and can be carried through to later stages of peptide building block synthesis. Resulting enantiopure or enriched leucine derivatives can then be used for stereodefined peptide construction, stereochemically controlled SAR studies, and reproducible manufacturing of chiral amino acid intermediates.

4. Process Chemistry Intermediate

H-DL-Leu-OBzl · p-tosylate is suitable for process chemistry intermediate preparation where protected amino acid forms are required for scalable, reproducible manufacturing routes. The combination of benzyl ester protection for the carboxyl group and N-acetyl protection for the amine supports predictable downstream transformations, including controlled deprotection and conversion to coupling-ready forms. The leucine isobutyl side chain is chemically stable under typical protection-handling conditions, which can simplify route design for fine chemical synthesis and specialty intermediate production. Tosylate association can aid in isolating and transporting the intermediate as a defined solid form, supporting industrial chemical manufacturing workflows that rely on protected amino acids as feedstocks for peptide building blocks and downstream derivatization.

5. Analytical Research Standards

H-DL-Leu-OBzl · p-tosylate can be employed as an analytical reference material in amino acid derivative characterization and method validation for protected amino acid and peptide-related analyses. The benzyl ester and N-acetyl functionality generate distinct chromatographic and spectroscopic signatures, enabling identification of leucine-derived intermediates during synthetic sequences. DL stereochemistry provides a defined racemate standard useful for assessing stereochemical separation performance in chiral HPLC or related analytical platforms. Downstream derivative formation from this intermediate can be tracked through analytical workflows, supporting quality control of protected amino acid synthesis, peptide building block preparation, and intermediate release testing in applied biochemical research and industrial manufacturing contexts.

1. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die

2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

3. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

4. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

5. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes